Why the study?
Elevated BNP is linked to poorer outcomes in ACS, and the in-hospital and long-term outcomes of multivessel versus single-vessel PCI in this specific high-risk subgroup remained to be compared.
Does multivessel PCI improve in-hospital and long-term outcomes compared to single-vessel PCI in patients with ACS and elevated BNP levels?
Does multivessel PCI improve in-hospital and long-term outcomes compared to single-vessel PCI in patients with ACS and elevated BNP levels?
Answers are grounded in this paper and cite their sources.
Brain natriuretic peptide (BNP) levels commonly rise in patients with heart failure and acute coronary syndrome (ACS), with increased levels being linked to poorer outcomes in patients with ACS. Studies show that multivessel PCI (mPCI) and single-vessel PCI (sPCI) carry similar mortality and complication rates. The aim of this study was to compare the in-hospital and long-term outcomes of mPCI and sPCI in patients with ACS and elevated BNP levels.
No takes yet. Share an insight, caveat, or question.
Kidess et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: